Focused on the Family: Development of a Family-Based Intervention Promoting the Transition to Adult Health Care for Adolescents with Type 1 Diabetes
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed Behavioral Family Systems Therapy for Diabetes Transition (BFST-DT), a virtual intervention to improve healthcare transition readiness for adolescents with type 1 diabetes (T1D). BFST-DT addresses family factors crucial for successful transition.
Area Of Science
- Pediatric Endocrinology
- Behavioral Health
- Healthcare Transition
Background
- Limited evidence exists for interventions supporting healthcare transition in youth with type 1 diabetes (T1D).
- Few interventions focus on modifiable individual and family factors influencing transition readiness.
- Developing effective transition strategies is critical for long-term health outcomes in T1D.
Purpose Of The Study
- To describe the development of Behavioral Family Systems Therapy for Diabetes Transition (BFST-DT).
- BFST-DT is a virtual, family-based intervention designed to enhance transition readiness in adolescents with T1D.
- To address the gap in interventions targeting family dynamics in T1D healthcare transitions.
Main Methods
- A three-phase development process was employed.
- Phase 1 involved focus groups with patients, caregivers, and providers to identify challenges.
- Phases 2 and 3 involved creating video vignettes and adapting an existing evidence-based family intervention.
Main Results
- BFST-DT is a 6-month virtual intervention combining multi-family group and individual family meetings.
- The intervention targets reciprocal interactions influencing individual and family transition readiness.
- It is the first family-focused intervention specifically for T1D transition readiness.
Conclusions
- BFST-DT represents a novel, family-centered approach to improving T1D healthcare transitions.
- The intervention is currently undergoing testing.
- Engaging patients, caregivers, and providers is essential for developing relevant and acceptable interventions.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...